USA flag logo/image

An Official Website of the United States Government

THE PRIMARY OBJECTIVE OF THIS PROJECT IS TO PROVIDE A NOVEL HEPARIN-LIKE…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4979
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4979
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ENVIVO PHARMACEUTICALS, INC.
ENVIVO PHARMACEUTICALS, INC. 3696 HAVEN AVE, STE B REDWOOD CITY, CA 94063
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: THE PRIMARY OBJECTIVE OF THIS PROJECT IS TO PROVIDE A NOVEL HEPARIN-LIKE MOLECULAR COMPONENT FOR SMALL BLOOD VESSEL PROSTHESES THAT WILL SIMULTANEOUSLY REDUCE OR PREVENT PERI- ANASTOMOTIC HYPERPLASIA AND REDUCE THROMBOGENICITY.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE PRIMARY OBJECTIVE OF THIS PROJECT IS TO PROVIDE A NOVEL HEPARIN-LIKE MOLECULAR COMPONENT FOR SMALL BLOOD VESSEL PROSTHESES THAT WILL SIMULTANEOUSLY REDUCE OR PREVENT PERI- ANASTOMOTIC HYPERPLASIA AND REDUCE THROMBOGENICITY. THE IMMEDIATE SPECIFIC AIM IS TO OBTAIN A NEW SUPPLY OF THIS MATERIAL FROM ITS INVERTEBRATE SOURCE AND TO TEST ITS ANTIPROLIFERATIVE AND ANTICOAGULANT ACTIVITY. THE FIRST PHASE OF THE PROJECT WILL INVOLVE EXTRACTION AND ASSAY FOR ANTIPROLIFERATIVE ACTIVITIES ON AORTIC SMOOTH MUSCLE CELLS. SUBSEQUENT RESEARCH WILL INVOLVE TESTS ON HUMAN ENDOTHELIAL CELLS, BONDING TO THE STRUCTURAL POLYMER, AND LATER, IN COLLABORATION WITH CARDIOVASCULAR SURGEONS, TESTS FOR DEVELOPMENT OF THE PRODUCT FOR CLINICAL USE. THE COMMERCIALVALUE OF THE PRODUCT ARISES FROM THE EXPANDING MARKET FOR CARDIOVASCULAR PROSTHESES IN GENERAL AND FOR IMPROVED SMALL BLOOD VESSEL PROSTHESES IN PARTICULAR.

Principal Investigator:

Murial m lippman
PRINCIPAL INVESTIGATOR
3015985025

Business Contact:

Small Business Information at Submission:

Ernaco Inc
3740 Capulet Terrace Silver Spring, MD 20906

EIN/Tax ID: 521188816
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No